Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

March 09, 2024 17:27 (London Time)

Phathom Pharmaceuticals

Youtube Subscribe

...

Sector: Pharmaceuticals
Ticker: PHAT
Sentiment: 0.1531
MarketCap: 519,278,876.0
High: 9.38 Low: 8.57

Open: 9.17 Close: 8.88 Change: -0.29

The 10 top things that an AI found about Phathom Pharmaceuticals and you do not know…

How much time have you spent trying to decide whether investing in Phathom Pharmaceuticals? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Phathom Pharmaceuticals are: …

Concept Map

...

Semantic Network

...

Stock Summary

Phathom Pharmaceuticals, Inc. focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada for an investigational potassium-competitive acid blocker (P-CAB).

Today's Summary

Phathom Pharmaceuticals reported earnings per share of -$1.39.39. Management to host conference call on Thursday, March 7, 2024, at 8:30 am. ET. Phathom pharmaceuticals to report fourth quarter and full year 2023 financial results and provide business update on thursday, march 7, 24. Phathom Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary Mar 7, 2024 at 4:02 pm GMT. Phathom pharmaceuticals inc down 3.80% to $9.36 after earnings miss. Wall Street median 12-month price target for Phathom.

Today's News

Phathom Pharmaceuticals reported earnings per share of -$1.39.39. Management to host conference call on Thursday, March 7, 2024, at 8:30 am. ET. Phathom pharmaceuticals to report fourth quarter and full year 2023 financial results and provide business update on thursday, march 7, 24. Phathom Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary Mar 7, 2024 at 4:02 pm GMT. Phathom pharmaceuticals inc down 3.80% to $9.36 after earnings miss. Wall Street median 12-month price target for Phathom.

Stock Profile

"Phathom Pharmaceuticals, Inc., biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada for an investigational potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan for the treatment of erosive gastroesophageal reflux disease; and in combination with antibiotics for the treatment of Helicobacter pylori infection. Phathom Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Florham Park, New Jersey."

Keywords

This document will help you to evaluate Phathom Pharmaceuticals without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Phathom Pharmaceuticals are: Phathom, report, Pharmaceuticals, earnings, pharmaceutical, quarter, result, and the most common words in the summary are: phathom, pharmaceutical, stock, market, report, top, inc, . One of the sentences in the summary was: Phathom pharmaceuticals to report fourth quarter and full year 2023 financial results and provide business update on thursday, march 7, 24. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #phathom #pharmaceutical #stock #market #report #top #inc.

Read more →

Related Results

...
March 09, 2024 17:27 (London Time)

Phathom Pharmaceuticals

Phathom Pharmaceuticals reported earnings per share of -$1.39.39. Management to host conference call on Thursday, March 7, 2024, at 8:30 am. ET. Pha…
Sector: Pharmaceuticals
Ticker: PHAT
Sentiment: 0.1531
MarketCap: 519,278,876.0
High: 9.38 Low: 8.57

Open: 9.17 Close: 8.88 Change: -0.29

Read more →
...
June 07, 2023 6:36 (London Time)

Phathom Pharmaceuticals

Wall Street analysts think 43.51% is the mean of analysts price targets for Phathom Pharmaceuticals. Institutional owners may ignore recent US$66m m…
Sector: Pharmaceuticals
Ticker: PHAT
Sentiment: -0.0772
MarketCap: 637,162,833.0
High: 11.81 Low: 11.52

Open: 11.71 Close: 11.64 Change: -0.07

Read more →